Cargando…

Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses

BACKGROUND: Early life exposures impact immune system development and therefore the risk of immune-mediated diseases, including inflammatory bowel disease (IBD). We systematically reviewed the impact of pre-, peri‑, and postnatal exposures up to the age of five years on subsequent IBD diagnosis. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Manasi, Sabino, João, Frias-Gomes, Catarina, Hillenbrand, Christen M., Soudant, Celine, Axelrad, Jordan E., Shah, Shailja C., Ribeiro-Mourão, Francisco, Lambin, Thomas, Peter, Inga, Colombel, Jean-Frederic, Narula, Neeraj, Torres, Joana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257976/ https://www.ncbi.nlm.nih.gov/pubmed/34308303 http://dx.doi.org/10.1016/j.eclinm.2021.100884

Ejemplares similares

The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review
por: Axelrad, Jordan E., et al.
Publicado: (2021)

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases
por: Axelrad, Jordan E., et al.
Publicado: (2019)

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance
por: Mahmoud, Remi, et al.
Publicado: (2019)

Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
por: Axelrad, Jordan E., et al.
Publicado: (2020)

Conjugal inflammatory bowel disease: a systematic review and European survey
por: Costa-Santos, Maria Pia, et al.
Publicado: (2021)

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
por: Mahmoud, Remi, et al.
Publicado: (2018)

Changing epidemiology of immune-mediated inflammatory diseases in immigrants: a systematic review of population-based studies
por: Agrawal, Manasi, et al.
Publicado: (2019)

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—a Systematic Review and Meta-analysis
por: Shah, Shailja C., et al.
Publicado: (2019)

Intestinal Ultrasound in Inflammatory Bowel Disease: A Valuable and Increasingly Important Tool
por: Frias-Gomes, Catarina, et al.
Publicado: (2021)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study
por: Hong, Simon J., et al.
Publicado: (2022)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
por: Ungaro, Ryan C., et al.
Publicado: (2022)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
por: Roda, Giulia, et al.
Publicado: (2016)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
por: Agrawal, Manasi, et al.
Publicado: (2020)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
por: Spiera, Emily, et al.
Publicado: (2022)

Steering a Course through the COVID-19 Pandemic: Should the SECURE-IBD Registry Influence Prescribing for Patients with Inflammatory Bowel Disease?
por: Gomes, Catarina Frias, et al.
Publicado: (2021)

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry
por: Spiera, Emily, et al.
Publicado: (2022)

Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY
por: Spiera, Emily, et al.
Publicado: (2022)

Inflammatory Bowel Disease Patients' Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey
por: Revés, Joana Branco, et al.
Publicado: (2021)

Obliterative Muscularization of the Small Bowel Submucosa in Fibrostenotic Crohn's Disease
por: McNeill, Matthew B., et al.
Publicado: (2020)

Role of endoscopy in inflammatory bowel disease
por: Bharadwaj, Shishira, et al.
Publicado: (2018)

Prognostication in inflammatory bowel disease
por: Spencer, Elizabeth A., et al.
Publicado: (2022)

Implications of the changing epidemiology of inflammatory bowel disease in a changing world
por: Agrawal, Manasi, et al.
Publicado: (2022)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies
por: Tepler, Adam, et al.
Publicado: (2021)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

Familial and ethnic risk in inflammatory bowel disease
por: Santos, Maria Pia Costa, et al.
Publicado: (2018)

Assessing journal author guidelines for systematic reviews and meta-analyses: findings from an institutional sample
por: Goldberg, Johanna, et al.
Publicado: (2022)

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19
por: Ungaro, Ryan C., et al.
Publicado: (2021)

A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data
por: Axelrad, Jordan E, et al.
Publicado: (2020)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
por: Agrawal, Manasi, et al.
Publicado: (2021)

Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease
por: Zhen, Jamie, et al.
Publicado: (2021)

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_svkkjnj3v03c382fe408n75l9p